Literature DB >> 18848556

Current directions in IBD therapy: what goals are feasible with biological modifiers?

William J Sandborn1.   

Abstract

Mesh：

Substances：

Year:  2008        PMID： 18848556     DOI： 10.1053/j.gastro.2008.09.053

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  27 in total

1.  An old herbal medicine with a potentially new therapeutic application in inflammatory bowel disease.

Authors:  Richard Li; Philip Alex; Mei Ye; Ting Zhang; Ling Liu; Xuhang Li
Journal:  Int J Clin Exp Med       Date:  2011-10-29

2.  Novel anti-inflammatory agent 3-[(dodecylthiocarbonyl)-methyl]-glutarimide ameliorates murine models of inflammatory bowel disease.

Authors:  Nobuki Ichikawa; Kenichiro Yamashita; Tohru Funakoshi; Shin Ichihara; Moto Fukai; Masaomi Ogura; Nozomi Kobayashi; Masaaki Zaitsu; Tadashi Yoshida; Susumu Shibasaki; Yasuyuki Koshizuka; Yusuke Tsunetoshi; Masanori Sato; Takahiro Einama; Michitaka Ozaki; Kazuo Umezawa; Tomomi Suzuki; Satoru Todo
Journal:  Inflamm Res       Date:  2015-12-18       Impact factor: 4.575

3.  Epstein-Barr virus replication linked to B cell proliferation in inflamed areas of colonic mucosa of patients with inflammatory bowel disease.

Authors:  Sumathi Sankaran-Walters; Kanat Ransibrahmanakul; Irina Grishina; Jason Hung; Enrique Martinez; Thomas Prindiville; Satya Dandekar
Journal:  J Clin Virol       Date:  2010-10-28       Impact factor: 3.168

4.  Crohn's disease: Adalimumab improves quality of life.

Authors:  Konstantinos A Papadakis
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-04       Impact factor: 46.802

Review 5.  Clinical implications of mucosal healing for the management of IBD.

Authors:  Guillaume Pineton de Chambrun; Laurent Peyrin-Biroulet; Marc Lémann; Jean-Frédéric Colombel
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-12-01       Impact factor: 46.802

Review 6.  Optimizing conventional therapies for inflammatory bowel disease.

Authors:  Miles P Sparrow; Peter M Irving; Stephen B Hanauer
Journal:  Curr Gastroenterol Rep       Date:  2009-12

Review 7.  Molecular Analysis of Inflammatory Bowel Disease: Clinically Useful Tools for Diagnosis, Response Prediction, and Monitoring of Targeted Therapy.

Authors:  Weiwei Jiang; Xuhang Li
Journal:  Mol Diagn Ther       Date:  2015-06       Impact factor: 4.074

8.  Evaluation of "top-down" treatment of early Crohn's disease by double balloon enteroscopy.

Authors:  Rong Fan; Jie Zhong; Zheng-Ting Wang; Shu-Yi Li; Jie Zhou; Yong-Hua Tang
Journal:  World J Gastroenterol       Date:  2014-10-21       Impact factor: 5.742

Review 9.  Impact of medical therapies on inflammatory bowel disease complication rate.

Authors:  Catherine Reenaers; Jacques Belaiche; Edouard Louis
Journal:  World J Gastroenterol       Date:  2012-08-07       Impact factor: 5.742

Review 10.  Optimizing biologic therapies for inflammatory bowel disease (ulcerative colitis and Crohn's disease).

Authors:  Marc Ferrante; Geert D'Haens; Paul Rutgeerts; Séverine Vermeire; Gert Van Assche
Journal:  Curr Gastroenterol Rep       Date:  2009-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.